Target intelligence / Profile preview

Chitin-binding pattern recognition receptor (null)

Target
null
Molecular classification
Receptor, Pattern recognition receptor (PRR), C-type lectin receptor (CLR), LysM domain-containing protein/receptor, Transmembrane protein
01

Overview

Chitin-binding pattern recognition receptors are innate immune receptors capable of binding chitin—a major structural polysaccharide found in fungal cell walls and some parasites. Key mammalian receptors include LYSMD3, which is expressed on human airway epithelial cells and binds both chitin and fungal spores, triggering pro-inflammatory cytokine production. FIBCD1 is another receptor, highly expressed in gut epithelium, binding chitin with calcium-dependence. In plants, LysM domain-containing PRRs such as CERK1, CEBiP, LYK4/5, and others promote recognition of chitin and initiate immune signaling. Recognition of chitin by these receptors is critical for defense against infection, but can contribute to allergic disorders like asthma when dysregulated. These receptors are characterized by carbohydrate-binding modules (notably LysM domains) and their function branches into broader PRR families also involved in sensing damage and infectious agents.

Other names
Chitin PRRLysM domain-containing receptorLysM receptorChitin receptorFIBCD1LYSMD3
02

Mechanism of action

Ligand-binding inhibition (blocking chitin-PRR interaction), receptor antagonism (antibodies or decoy proteins prevent signaling), interference with downstream signaling pathways (inflammation/cytokine production)

03

Biological functions

Immune response (innate immunity)Inflammatory responsePathogen recognition (particularly fungi)Cytokine productionSignal transduction
04

Disease associations

Infection (fungal, parasitic)Allergy (e.g., asthma)InflammationPossibly cancer, fibrosis, tissue remodeling via downstream pathways
05

Safety considerations

Potential immunosuppressionIncreased susceptibility to fungal or parasitic infection if blockedRisk of altering epithelial barrier or inflammatory response, particularly in the lung and GI tractPossible off-target effects on tissue remodeling and allergy/asthma responses
06

Interacting drugs

soluble LYSMD3 protein

1 more in the full profile.

07

Biomarkers

Presence or level of specific chitin-binding PRRs (e.g., LYSMD3 expression in lung epithelium)Cytokine profile after chitin exposure

Beyond the preview

Go deeper on Chitin-binding pattern recognition receptor (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chitin-binding pattern recognition receptor (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call